194 related articles for article (PubMed ID: 35963130)
21. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity.
Tokala R; Sana S; Lakshmi UJ; Sankarana P; Sigalapalli DK; Gadewal N; Kode J; Shankaraiah N
Bioorg Chem; 2020 Dec; 105():104357. PubMed ID: 33091673
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.
Yu JY; Li XQ; Wei MX
Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384
[TBL] [Abstract][Full Text] [Related]
24. Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.
Grigolo TA; Braga CB; Ornelas C; Russowsky D; Ferreira-Silva GA; Ionta M; Pilli RA
Bioorg Chem; 2021 Nov; 116():105292. PubMed ID: 34509797
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
[TBL] [Abstract][Full Text] [Related]
26. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
27. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
Jiang YY; Wu S; Wu YW; Gao Y; Chong D; Sun C; Wei MY; Gu YC; Shao CL; Gu Y
Eur J Med Chem; 2022 Oct; 240():114598. PubMed ID: 35849940
[TBL] [Abstract][Full Text] [Related]
28. New aryl-/heteroarylpiperazine derivatives of 1,7-dimethyl-8,9-diphenyl-4-azatricyclo[5.2.1.0
Napiórkowska M; Kurpios-Piec D; Kiernozek-Kalińska E; Leśniak A; Klawikowska M; Bujalska-Zadrożny M
Bioorg Med Chem; 2023 Dec; 96():117518. PubMed ID: 37951135
[TBL] [Abstract][Full Text] [Related]
29. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
30. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
31. Nitroimidazoles Part 10. Synthesis, crystal structure, molecular docking, and anticancer evaluation of 4-nitroimidazole derivatives combined with piperazine moiety.
Al-Soud YA; Saber SOW; Shtaiwi A; Alsawakhneh SO; Alhelal KAS; Salman QFA; Abu-Qatouseh L; Khanfar MA; Al-Qawasmeh RA
Z Naturforsch C J Biosci; 2023 Mar; 78(3-4):93-103. PubMed ID: 35589618
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity evaluation of podophyllotoxin-linked bile acid derivatives as potential anti-liver cancer agents.
Cai DS; Lou SY; Huo S; Yang YQ; Gao F; Pi WM; Chen KD; Wang C; Yang XY; Jiao JY; Xu B; Wang PL; Lei HM
Bioorg Chem; 2022 Nov; 128():106066. PubMed ID: 35964500
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of a novel class of ethacrynic acid derivatives containing triazoles as potent anticancer agents.
El Abbouchi A; El Brahmi N; Hiebel MA; Bignon J; Guillaumet G; Suzenet F; El Kazzouli S
Bioorg Chem; 2021 Oct; 115():105293. PubMed ID: 34426162
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
36. Apoptotic Effect of Novel Benzimidazole Derivatives Bearing Pyridyl/Pyrimidinyl Piperazine Moiety.
Çiftçi GA; Temel HE; Yurttaş L
Anticancer Agents Med Chem; 2022; 22(9):1780-1792. PubMed ID: 34238172
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
38. In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors.
Desai S; Desai V; Shingade S
Bioorg Chem; 2020 Jan; 94():103382. PubMed ID: 31662214
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
Xu Z; Pan B; Chen L; Xu D
Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
[TBL] [Abstract][Full Text] [Related]
40. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]